drugset / Trial / NCT04583046

Effects of Iloprost on Pulmonary Oxygenation in Obese Patients During One-lung Ventilation

NCT04583046

Completed 78 enrolled Yonsei University
RandomizedParallel-groupDouble-blindTreatment

Summary

One lung ventilation (OLV) is essential during thoracic surgery. During OLV, intrapulmonary shunt can be increased resulting hypoxemia. Although OLV technique had been advanced so far, hypoxemia during OLV reaches about 10% in spite of inspired oxygen fraction 100%. Iloprost is a prostaglandin analogue used for pulmonary hypertension, which can decrease pulmonary artery resistance by selectively dilating pulmonary artery. In this prospective, randomized, double blind study, the investigator is planning to investigate the effects of iloprost on respiratory physiology (intrapulmonary shunt, deadspace, oxygenation, etc) in obese patients.

Timeline

Start
2020-11-02
Primary completion
2025-09-26
Completion
2025-09-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Iloprost Other / unclassified Inhaled

Indications